Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide dose/frequency optimization in uncontrolled acromegaly
NCT00372697Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2005
- Primary completion
- Oct 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of octreotide in acromegaly, sponsored by Novartis. Started Dec 2005; status: completed.
02
Drugs
octreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00372697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00372697.